Immunocore Holdings (IMCR) Consolidated Net Income: 2021-2025
Historic Consolidated Net Income for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$196,000.
- Immunocore Holdings' Consolidated Net Income fell 102.24% to -$196,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.3 million, marking a year-over-year increase of 37.83%. This contributed to the annual value of -$51.1 million for FY2024, which is 7.60% up from last year.
- As of Q3 2025, Immunocore Holdings' Consolidated Net Income stood at -$196,000, which was up 98.10% from -$10.3 million recorded in Q2 2025.
- Over the past 5 years, Immunocore Holdings' Consolidated Net Income peaked at $8.7 million during Q3 2024, and registered a low of -$52.6 million during Q4 2021.
- Moreover, its 3-year median value for Consolidated Net Income was -$11.6 million (2024), whereas its average is -$10.2 million.
- Per our database at Business Quant, Immunocore Holdings' Consolidated Net Income skyrocketed by 864.24% in 2024 and then slumped by 102.24% in 2025.
- Over the past 4 years, Immunocore Holdings' Consolidated Net Income (Quarterly) stood at -$52.6 million in 2021, then reached -$19.7 million in 2023, then declined by 20.48% to -$23.8 million in 2024, then tumbled by 102.24% to -$196,000 in 2025.
- Its last three reported values are -$196,000 in Q3 2025, -$10.3 million for Q2 2025, and $5.0 million during Q1 2025.